Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Loss of angiopoietin-2 leads to region-specific brain malformations and blood-brain barrier leakage
Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe
Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe
View: Text | PDF
Research Article Cell biology Vascular biology

Loss of angiopoietin-2 leads to region-specific brain malformations and blood-brain barrier leakage

  • Text
  • PDF
Abstract

Angiopoietin-2 (ANGPT2) is known to destabilize vascular barriers in most peripheral organs; however, its role in the brain vasculature remains poorly understood. To investigate its physiological function within the brain vasculature, we analyzed constitutive Angpt2-knockout mice in adulthood. We showed that loss of ANGPT2 leads to region-specific vascular malformations and blood-brain barrier (BBB) dysfunction, resulting in differential permeability to 1 kDa and 70 kDa fluorescent tracers. Notably, overt vascular malformations appeared only in select brain regions that allowed leakage of both tracers. These malformations were characterized by dilated, intertwined, and sprouting endothelial cells, surrounded by reactive perivascular cells, along with high levels of astrocyte- and neuron-derived vascular endothelial growth factor A (VEGFA) and elevated expression of the vascular receptors VEGF receptor 2 (KDR) and neuropilin-1 (NRP1). Other cortical areas without obvious malformations exhibited significant leakage of the 1 kDa tracer. We also demonstrated that different cell types took up the tracers after passing the BBB. Our findings identified ANGPT2 as an important factor involved in the regulation of cerebrovascular architecture, barrier integrity, and endothelial-parenchymal interactions, and uncovered surprising differences in the leakage patterns and cellular uptake of two widely used BBB tracers.

Authors

Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe

×

Figure 2

BBB permeability and endothelial junctions in Angpt2-KO brains.

Options: View larger image (or click on image) Download as PowerPoint
BBB permeability and endothelial junctions in Angpt2-KO brains.
(A) Tile...
(A) Tile scans of PECAM1 (gray) IF with 70 kDa TMR-dextran (red) and 1 kDa A488-cadaverine (green) on sagittal sections (n = 4). High-magnification images of different modes of leakage in malformed (SS4–6, CP) and non-malformed vasculature (AI) are shown. Yellow arrow points to piriform area (PIR) with occasional A488-cadaverine leakage. (B) Illustration of intravenous retro-orbital approach used for tracer injection. (C and D) Quantification of 70 kDa TMR-dextran (C) and 1 kDa A488-cadaverine (D) leakage in different cortical regions (AI, ORB, MO, SS1–3, SS4–6, and VIS) and CP (n = 4). Data were normally distributed, and a 2-way ANOVA with Tukey’s multiple-comparison test was performed to evaluate significance. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (E) Representative images of PECAM1 (yellow) and TER119 (cyan) IF and 70 kDa TMR-dextran (red) in SS4–6 from Angpt2 WT (n = 5) and KO (n = 6). High-magnification images of red blood cell extravasation in malformed vasculature are shown. (F) Representative images of PECAM1 (red), CLDN5 (cyan), and CDH5 (yellow) IF in CP from Angpt2 WT (n = 5) and KO (n = 6). High-magnification images of a regular vascular stretch in Angpt2 WT and a dilated and tangled vascular stretch in Angpt2 KO are shown. Scale bars: 25 μm. (G) Representative images of PECAM1 (yellow) and CLDN5 (cyan) IF and 70 kDa TMR-dextran (red) in CP (n = 4). High-magnification images of parenchymal dextran leakage in malformed vasculature are shown. Scale bars: 100 μm (A); 50 μm (E); 25 μm (F); 50 and 10 μm (G).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts